Literature DB >> 18609740

From skin to bone: translational perspectives on psoriatic disease.

Christopher T Ritchlin1.   

Abstract

In recent years, translational research has provided fresh insights into the mechanisms that underlie both skin and joint inflammation in psoriatic arthritis (PsA). Application of immunological and molecular techniques to the study of involved tissues, combined with magnetic resonance imaging and relevant preclinical models, has unveiled pivotal inflammatory cascades and cytokine networks that lead to sustained inflammation and altered tissue architecture. In this brief overview of a presentation from the 2007 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) the key pathophysiologic events associated with inflammation in psoriatic plaques, synovial membranes, and soft tissues (entheses, tendons), and with abnormal bone remodeling are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18609740

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study.

Authors:  Luisa Costa; Francesco Caso; Roberta Ramonda; Antonio Del Puente; Luca Cantarini; Md Abud Darda; Paolo Caso; Mariagrazia Lorenzin; Ugo Fiocco; Leonardo Punzi; Raffaele Scarpa
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Genetics of susceptibility and treatment response in psoriatic arthritis.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Nat Rev Rheumatol       Date:  2011-11-08       Impact factor: 20.543

3.  Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients.

Authors:  Luisa Costa; Francesco Caso; Mariangela Atteno; Antonio Del Puente; Md Abud Darda; Paolo Caso; Augusta Ortolan; Ugo Fiocco; Roberta Ramonda; Leonardo Punzi; Raffaele Scarpa
Journal:  Clin Rheumatol       Date:  2014-06       Impact factor: 2.980

4.  The quest for a biomarker of circulating osteoclast precursors.

Authors:  Christopher Ritchlin
Journal:  Arthritis Res Ther       Date:  2009-06-17       Impact factor: 5.156

5.  Psoriatic arthritis: pharmacoeconomic considerations.

Authors:  Ignazio Olivieri; Lorenzo Giovanni Mantovani; Salvatore D'Angelo; Angela Padula; Simona de Portu
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

Review 6.  The microbiome and psoriatic arthritis.

Authors:  Hester Eppinga; Sergey R Konstantinov; Maikel P Peppelenbosch; H Bing Thio
Journal:  Curr Rheumatol Rep       Date:  2014-03       Impact factor: 4.592

Review 7.  The Clinical and Cost Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis: A Critique of the Evidence.

Authors:  Joanne O'Connor; Stephen Rice; Alison Smith; Mark Rodgers; Rocio Rodriguez Lopez; Dawn Craig; Nerys Woolacott
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981

8.  A sonographic spectrum of psoriatic arthritis: "the five targets".

Authors:  Marwin Gutierrez; Emilio Filippucci; Rossella De Angelis; Giorgio Filosa; David Kane; Walter Grassi
Journal:  Clin Rheumatol       Date:  2009-10-24       Impact factor: 2.980

9.  Ultrasound assessment in psoriatic arthritis (PsA) and psoriasis vulgaris (non-PsA): which sites are most commonly involved and what features are more important in PsA?

Authors:  Yuanjiao Tang; Shan Cheng; Yujia Yang; Xi Xiang; Liyun Wang; Lingyan Zhang; Li Qiu
Journal:  Quant Imaging Med Surg       Date:  2020-01

10.  Psoriatic arthritis: an update.

Authors:  Peter Lloyd; Caitriona Ryan; Alan Menter
Journal:  Arthritis       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.